Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $48.7100 (2.31%) ($48.7100 - $48.7100) on Wed. Dec. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 60 | Latest Price | $48.7100(2.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(43%) IWO(42%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.725% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-12%) TBT(-6%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $48.79(-0.16%) | 10 Day Moving Average | $48.17(1.12%) | 20 Day Moving Average | $47.32(2.94%) | To recent high | -2.8% | To recent low | 73.5% | Market Cap | $7.133b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |